Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The innate immune pattern-recognition and danger-sensing pathways represent the primary sensory apparatus of the host immune system, responsible for detecting and responding to biological threats. These pathways are centered around Pattern Recognition Receptors (PRRs), including Toll-like receptors (TLRs), NOD-like receptors (NLRs), RIG-I-like receptors (RLRs), and cytosolic DNA sensors such as cGAS-STING. PRRs identify conserved microbial motifs known as Pathogen-Associated Molecular Patterns (PAMPs) and endogenous signals of cellular damage called Damage-Associated Molecular Patterns (DAMPs). Activation of these receptors initiates complex signaling cascades that culminate in the production of pro-inflammatory cytokines, chemokines, and interferons, which orchestrate the initial immune response and shape subsequent adaptive immunity. Dysregulation of these pathways is a hallmark of numerous diseases, including chronic inflammatory conditions, autoimmune disorders, and cancer. Consequently, these pathways are major therapeutic targets; agonists are being developed to 'warm up' cold tumors in oncology, while antagonists and inhibitors are explored to treat hyperinflammatory states like sepsis and COVID-19.
Modulation of pattern recognition receptors (PRRs) to either stimulate innate immune responses for anti-tumor or anti-viral activity, or to inhibit excessive inflammatory signaling in autoimmune and hyperinflammatory conditions.
10 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Innate immune pattern-recognition and danger-sensing pathways (PRR pathways).